Lurafic 80mg Tablet contains Lurasidone, an atypical antipsychotic agent indicated for the treatment of schizophrenia and bipolar depression. Lurasidone exerts its therapeutic effects primarily through antagonism of dopamine D2 and serotonin 5-HT2A receptors, which helps to restore the balance of neurotransmitters in the brain. This medication is effective in reducing symptoms such as hallucinations, delusions, mood swings, and cognitive disturbances associated with these psychiatric disorders. Lurafic 80mg is typically administered once daily, with or without food, and dosage adjustments should be guided by clinical response and tolerability. Common adverse effects may include nausea, somnolence, akathisia, and extrapyramidal symptoms, though it generally has a favorable safety profile compared to typical antipsychotics. Caution is advised in patients with a history of cardiovascular disease, seizures, or metabolic disorders, and regular monitoring of metabolic parameters, including blood glucose and lipid levels, is recommended during treatment. Lurafic should be used under strict medical supervision, with careful consideration of potential drug interactions, particularly with CYP3A4 inhibitors or inducers. This medication is not approved for use in elderly patients with dementia-related psychosis due to increased risk of mortality.